Company
aimbio.com
全产业链疫苗集团
- Status
- Operatingas of 2026-09-21
- Business model
- B2B
- Customers
- 向中国31个省、自治区及直辖市销售疫苗产品
- Legal name
- 艾美疫苗股份有限公司
Record updated 28 September 2026
About
AIM Vaccine is a large privately owned, fully integrated vaccine group in China. Its business spans the entire industry value chain from R&D to manufacturing to commercialization, and it sells vaccine products to all 31 provinces, autonomous regions and municipalities in China.
Products
- Other
- ACYW135群脑膜炎球菌多糖疫苗(MPSV4)
- Other
- 冻干人用狂犬病疫苗(Vero细胞)
- Other
- 双价肾综合征出血热灭活疫苗(Vero细胞)
- Other
- 甲型肝炎灭活疫苗(人用人二倍体细胞)
- Other
- 腮腺炎减毒活疫苗
- Other
- 重组乙型肝炎疫苗(汉逊酵母)